RxDoctor Payments Data

Edward Chang

Orthopaedic Surgery · Fairfax, VANPI 1235373648

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (28.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Arthrex at 42.3% of the total.

$18,257in general payments, 2019–2025

Across 138 payments — averaging $132.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$8K
  • Supreme Orthopedic Systems, LLC$5K
  • Avanos Medical$3K
  • Smith+Nephew$796
  • Stryker$305
  • Linvatec Corporation$269
  • plus $896 from 7 others
$202,680in research payments, 2019–2025

Across 7 payments — averaging $28,954 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Miach Orthopaedics, Inc.$167K
  • Arthrex$36K

What the payments were for

  • Consulting fees$9765%
  • Speaking & faculty fees$1,89610%
  • Travel & lodging$5,08028%
  • Food & beverage$5,06128%
  • Education$5,24529%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex81$7,732
Supreme Orthopedic Systems, LLC28$5,281
Avanos Medical6$2,979
Smith+Nephew7$796
Stryker5$305
Linvatec Corporation2$269
Stratus Medical, LLC2$221
Zimmer Biomet2$161
Miach Orthopaedics, Inc.1$136
Xiros Inc1$135
Abanza Inc.1$119
Axogen1$81
Lima USA, Inc.1$43

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,257 in reported general payments places this provider in the 75th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$56,938
Medicare patients
133
Services billed
4,331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium13$689
Meloxicam16$25

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →